ArticleHaematologica2017
Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.
Open access · goldAbstract readLetter
In one paragraph
Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 36 citations in OpenAlex.
- Article
- The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma.Blood cancer journal · 2025Article
- Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.Blood advances · 2024Article
- SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.Scientific reports · 2024Article
- Article
- Review
- Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.Nature communications · 2022Article
- Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.Journal of cancer research and clinical oncology · 2022Article
- A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022Article
- Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma.Leukemia · 2022Article
- Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation.Nature communications · 2021Article
- A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021Article
- Article
- Consistency of the Moreau CLL score.Journal of clinical laboratory analysis · 2018Article
- The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.Nature medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 10 institutions in 5 countries.
Alba NavarroInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Guillem ClotInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Alejandra Martínez-TrillosInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Magda PinyolCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.
Pedro JaresInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Blanca González-FarréInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Daniel MartínezInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Nicola TrimWest Midlands Regional Genetics Laboratory, Birmingham, UK.
Verónica FernándezInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Neus VillamorInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Dolors ColomerInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Dolors CostaInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Itziar SalaverriaInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
David Martín-GarciaInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Wendy ErberSchool of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, WA, Australia.
Cristina LópezInstitute of Human Genetics, University Kiel, Germany.
Sandrine JayneErnest and Helen Scott Haematological Research Institute, Department of Biochemistry, University of Leicester, UK.
Reiner SiebertInstitute of Human Genetics, University Kiel, Germany.
Martin J S DyerErnest and Helen Scott Haematological Research Institute, Department of Biochemistry, University of Leicester, UK.
Adrian WiestnerNational Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Wyndham H WilsonLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Marta AymerichInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Armando López-GuillermoInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Àlex SánchezDepartment of Genetics Microbiology and Statistics, University of Barcelona, Spain.
Elías CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain.
Estella MatutesCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.
Sílvia BeàInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain sbea@clinic.cat.
Centro de Investigación Biomédica en Red de Cáncer · ESUniversitat de Barcelona · ESUniversity Hospital Ulm · DEUniversity of Leicester · GBCenter for Cancer Research · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESNational Heart Lung and Blood Institute · USUniversity of Western Australia · AUVall d'Hebron Institut de Recerca · ESWessex Regional Genetics Laboratory · GB
Funding
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapyZIAHL002346 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI WIESTNER, ADRIAN U · 2009 to 2025
$29.8MNovel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosisZIAHL005076 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI WIESTNER, ADRIAN U · 2009 to 2019
$3.2MPhase I study of bortezomib and DA-EPOCH-R with microarray in DLBCLZIABC010717 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WILSON, WYNDHAM H · 2009 to 2021
$1.7MMedical Research Council MC_U132670597
Abstract
PubMed holds no abstract for this paper.
Indexed as
AlgorithmsB-LymphocytesGene Expression ProfilingHumansLeukemia, Lymphocytic, Chronic, B-CellLymphoproliferative DisordersTranscription, Genetic
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.